Skip to Main Content

Paper Details

Does a Multiple Myeloma Polygenic Risk Score Predict Overall Survival of Patients with Myeloma?
Cancer Epidemiol Biomarkers Prev
3
2022
-, 24 SNP MM, Lymphoma, Multiple Myeloma, Myeloma, OS, POT1-AS1, POT1-AS1-, PRS, Patients, TNFRSF13B, cancers, colorectum, melanoma, multiple myeloma, myeloma, patient, risk SNP, risk loci, risk variants, rs2170352, rs4273077, susceptibility loci
Author NameAffiliation
Elad ZivUniversity of California San Francisco Helen Diller Family Comprehensive Cancer Center
Elad ZivUniversity of California San Francisco Helen Diller Family Comprehensive Cancer Center
Mitchell J Machiela
Mitchell J Machiela
Stephen J Chanock
Stephen J Chanock
Wendy CozenSusan and Henry Samueli College of Health Sciences, Chao Family Comprehensive Cancer Center, University of California at Irvine
Graham G Giles
Graham G GilesThe University of Melbourne
Graham G GilesSchool of Clinical Sciences at Monash Health, Monash University
Roger L Milne
Roger L MilneThe University of Melbourne
Roger L MilneSchool of Clinical Sciences at Monash Health, Monash University
Sundararajan Vincent RajkumarMayo Clinic
Rui Manuel ReisLife and Health Sciences Research Institute (ICVS), University of Minho
Rui Manuel ReisMolecular Oncology Research Center, Barretos Cancer Hospital
Niels WeinholdUniversity of Heidelberg
Niels WeinholdGerman Cancer Research Center (DKFZ)
Sonja I Berndt
Federico CanzianGerman Cancer Research Center (DKFZ)
  • 1 - 20

Datasets

Release 1.2